Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
4135690
Title:
(S)-(4,5-DIHYDRO-7 H-THIÉNO[2,3-C]PYRAN-7-YL)-N-MÉTHYLMÉTHANAMINE POUR LE TRAITEMENT, LA PRÉVENTION ET/OU LA GÉSTION D'UNE TROUBLE NEUROLOGIQUE ET/OU PSYCHIATRIQUE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
217235209
WO application number:
US2021026953
Type:
European patent granted for BE
Status:
Open
Publication number:
4135690
WO publication number:
WO2021211489
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
13/04/2021
Grant date:
25/03/2026
EP publication date:
22/02/2023
WO publication date:
21/10/2021
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
25/03/2026
EP B1 publication date:
25/03/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
13/04/2041
Applicant
Name:
Sumitomo Pharma America, Inc.
Legal Form:
From:
25/03/2026
Address:
84 Waterford Drive, Marlborough, MA 01752, United States (US)
To:
Agent
Name:
CABINET BEDE
Legal Form:
From:
26/03/2026
Address:
Boulevard Général Wahis 15, 1030, BRUXELLES, Belgium (BE)
To:
Inventor
1
Name:
BOWEN, Carrie A.
Legal Form:
Address:
Marlborough, Massachusetts 01752, United States (US)
2
Name:
HOPKINS, Seth Cabot
Legal Form:
Address:
Marlborough, Massachusetts 01752, United States (US)
3
Name:
SYNAN, Colleen M.
Legal Form:
Address:
Marlborough, Massachusetts 01752, United States (US)